139 related articles for article (PubMed ID: 38607517)
1. Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration.
Tao CY; Wu XL; Song SS; Tang Z; Zhou YF; Tian MX; Jiang XF; Fang Y; Zhu GQ; Huang R; Qu WF; Gao J; Chu TH; Yang R; Chen JF; Zhao QF; Ding ZB; Dai Z; Zhou J; Liu WR; Shi YH; Fan J
Cell Oncol (Dordr); 2024 Apr; ():. PubMed ID: 38607517
[TBL] [Abstract][Full Text] [Related]
2. Glutathione peroxidase family and survival prognosis in patients with renal cell carcinoma.
Li J; Huo S; Zhang R; Shi C; Sun N; Liu Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):562-572. PubMed ID: 35753726
[TBL] [Abstract][Full Text] [Related]
3. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway.
Xiao CL; Zhong ZP; Lü C; Guo BJ; Chen JJ; Zhao T; Yin ZF; Li B
J Integr Med; 2023 Mar; 21(2):184-193. PubMed ID: 36781361
[TBL] [Abstract][Full Text] [Related]
4. LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3.
Shu G; Su H; Wang Z; Lai S; Wang Y; Liu X; Dai L; Bi Y; Chen W; Huang W; Zhou Z; He S; Dai H; Tang B
J Exp Clin Cancer Res; 2021 Jan; 40(1):45. PubMed ID: 33499874
[TBL] [Abstract][Full Text] [Related]
5. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma.
Bamodu OA; Chang HL; Ong JR; Lee WH; Yeh CT; Tsai JT
Cells; 2020 Mar; 9(3):. PubMed ID: 32197467
[TBL] [Abstract][Full Text] [Related]
6. miR-3682-3p Activated by c-Myc Aggravates the Migration and Stemness in Hepatocellular Carcinoma Cells by Regulating PTEN/PI3K/AKT/β-Catenin Signaling.
Zhang Y; Cai H; Wu MH; Zhu DH; Wang XY; Chen ZY; Yang L; Liu P; Liu Z
Dig Dis; 2023; 41(3):447-457. PubMed ID: 36366818
[TBL] [Abstract][Full Text] [Related]
7. Furanocoumarin Notopterol: Inhibition of Hepatocellular Carcinogenesis through Suppression of Cancer Stemness Signaling and Induction of Oxidative Stress-Associated Cell Death.
Huang TY; Yang CK; Chen MY; Yadav VK; Fong IH; Yeh CT; Cherng YG
Nutrients; 2023 May; 15(11):. PubMed ID: 37299411
[TBL] [Abstract][Full Text] [Related]
8. Silencing CDCA8 Suppresses Hepatocellular Carcinoma Growth and Stemness via Restoration of ATF3 Tumor Suppressor and Inactivation of AKT/β-Catenin Signaling.
Jeon T; Ko MJ; Seo YR; Jung SJ; Seo D; Park SY; Park KU; Kim KS; Kim M; Seo JH; Park IC; Kim MJ; Bae JH; Song DK; Cho CH; Lee JH; Lee YH
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33801424
[TBL] [Abstract][Full Text] [Related]
9. Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma.
Liu B; Fang X; Kwong DL; Zhang Y; Verhoeft K; Gong L; Zhang B; Chen J; Yu Q; Luo J; Tang Y; Huang T; Ling F; Fu L; Yan Q; Guan XY
J Exp Clin Cancer Res; 2022 May; 41(1):182. PubMed ID: 35610614
[TBL] [Abstract][Full Text] [Related]
10. Heat shock protein 22 (HSPB8) reduces the migration of hepatocellular carcinoma cells through the suppression of the phosphoinositide 3-kinase (PI3K)/AKT pathway.
Matsushima-Nishiwaki R; Toyoda H; Takamatsu R; Yasuda E; Okuda S; Maeda A; Kaneoka Y; Yoshimi N; Kumada T; Kozawa O
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1629-1639. PubMed ID: 28456666
[TBL] [Abstract][Full Text] [Related]
11. Glutathione peroxidase 8 is transcriptionally regulated by HIFα and modulates growth factor signaling in HeLa cells.
Bosello-Travain V; Forman HJ; Roveri A; Toppo S; Ursini F; Venerando R; Warnecke C; Zaccarin M; Maiorino M
Free Radic Biol Med; 2015 Apr; 81():58-68. PubMed ID: 25557012
[TBL] [Abstract][Full Text] [Related]
12. microRNA-448 inhibits stemness maintenance and self-renewal of hepatocellular carcinoma stem cells through the MAGEA6-mediated AMPK signaling pathway.
Guo JC; Yang YJ; Zhang JQ; Guo M; Xiang L; Yu SF; Ping H; Zhuo L
J Cell Physiol; 2019 Dec; 234(12):23461-23474. PubMed ID: 31232474
[TBL] [Abstract][Full Text] [Related]
13. SENP2 Reduces Hepatocellular Carcinoma Stemness and Improves Sorafenib Sensitivity Through Inactivating the AKT/GSK3β/CTNNB1 Pathway.
Tang X; Liu B; Zhang C; Tang W; Liang S; Xiao Y; Deng R; Li Z
Front Oncol; 2021; 11():773045. PubMed ID: 34950583
[TBL] [Abstract][Full Text] [Related]
14. Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma.
Chang TS; Chen CL; Wu YC; Liu JJ; Kuo YC; Lee KF; Lin SY; Lin SE; Tung SY; Kuo LM; Tsai YH; Huang YH
PLoS One; 2016; 11(2):e0149897. PubMed ID: 26919045
[TBL] [Abstract][Full Text] [Related]
15. AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation.
Bian X; Shi D; Xing K; Zhou H; Lu L; Yu D; Wu W
Clin Transl Med; 2021 Mar; 11(3):e352. PubMed ID: 33783988
[TBL] [Abstract][Full Text] [Related]
16. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
17. B4GALNT1 promotes hepatocellular carcinoma stemness and progression via integrin α2β1-mediated FAK and AKT activation.
Tang Y; Xu Z; Xu F; Ye J; Chen J; He J; Chen Y; Qi C; Huang H; Liu R; Shan H; Xiao F
JHEP Rep; 2023 Dec; 5(12):100903. PubMed ID: 37965158
[TBL] [Abstract][Full Text] [Related]
18. GPx8 regulates apoptosis and autophagy in esophageal squamous cell carcinoma through the IRE1/JNK pathway.
Yin X; Zhang P; Xia N; Wu S; Liu B; Weng L; Shang M
Cell Signal; 2022 May; 93():110307. PubMed ID: 35288240
[TBL] [Abstract][Full Text] [Related]
19. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma.
Gao X; Sheng Y; Yang J; Wang C; Zhang R; Zhu Y; Zhang Z; Zhang K; Yan S; Sun H; Wei J; Wang X; Yu X; Zhang Y; Luo Q; Zheng Y; Qiao P; Zhao Y; Dong Q; Qin L
J Exp Clin Cancer Res; 2018 Jul; 37(1):179. PubMed ID: 30064482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
